摘要 |
An oxazolidine derivative represented by general formula (I), a salt thereof, a process for the production thereof, an antihyperlipidemic containing the same as the active ingredient, and a method of curing hyperlipidemia by administering the same, wherein R<1>, R<2> and R<3> represent each H, optionally halogenated alkyl, optionally halogenated alkoxy, OH, halo, NO2, optionally acetylated or alkylated amino, COOH, alkoxycarbonyl, CN, alkanoyl or 2-oxazolyl, provided that R<1> and R<2> may be combined with each other to represent -(CH2)p- or -O-(CH2)q-O-, wherein p represents 3 to 5 and q represents 1 to 3, thus forming a cyclic structure; m and n represent each 0 or 1; R<4> and R<5> represent each H or alkyl; X represents C or N; Y represents CH2OH, CHO or COOR<6>, R<6> representing alkyl, benzyl or H; A represents alkylene, carbonyl or sulfonyl; B represents alkylene; E represents optionally halogenated alkylene or alkenylene; and Z represents O or S; provided that the case where n is 0, m is 1 and Y is CH2OH and the case where n is 0 and Y is COOR<6>, R<6> being alkyl, are excluded. |
申请人 |
TAIHO PHARMACEUTICAL CO., LTD. |
发明人 |
YANO, SHINGO;OHNO, TOMOYASU;OGAWA, KAZUO;YAMADA, HARUO;SHIRASAKA, TETSUHIKO;KAWAMURA, HIROYUKI;WATANABE, SHINICHI |